心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 EHRA意见书：内分泌疾病患者的心律失常管理和设备治疗

2018-03-16 欧洲心律学会 Europace. 2018 Mar 16.

内分泌疾病心律失常

2018年3月，欧洲心律学会(EHRA)发布了内分泌疾病患者的心律失常管理和设备治疗的意见书，内分泌疾病和各种类型型心律失常相关，包括房颤，室性心动过速，室颤以及心动过缓。本文主要内容包括特殊内分泌疾病心律失常的管理，内分泌疾病相关心律失常的预防以及卒中风险评估，内分泌疾病相关性心律失常的导管消融治疗等。

中文标题：

2018 EHRA意见书：内分泌疾病患者的心律失常管理和设备治疗

英文标题：

European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS).

发布机构：

欧洲心律学会

发布日期：

2018-03-16

简要介绍：

2018年3月，欧洲心律学会(EHRA)发布了内分泌疾病患者的心律失常管理和设备治疗的意见书，内分泌疾病和各种类型型心律失常相关，包括房颤，室性心动过速，室颤以及心动过缓。本文主要内容包括特殊内分泌疾病心律失常的管理，内分泌疾病相关心律失常的预防以及卒中风险评估，内分泌疾病相关性心律失常的导管消融治疗等。

 

拓展指南：与心律失常相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 EHRA意见书：内分泌疾病患者的心律失常管理和设备治疗)] GetToolGuiderByIdResponse(projectId=1, id=fc8a31c0015e3191, title=2018 EHRA意见书：内分泌疾病患者的心律失常管理和设备治疗, enTitle=European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)., guiderFrom=Europace. 2018 Mar 16., authorId=null, author=, summary=2018年3月，欧洲心律学会(EHRA)发布了内分泌疾病患者的心律失常管理和设备治疗的意见书，内分泌疾病和各种类型型心律失常相关，包括房颤，室性心动过速，室颤以及心动过缓。本文主要内容包括特殊内分泌疾病心律失常的管理，内分泌疾病相关心律失常的预防以及卒中风险评估，内分泌疾病相关性心律失常的导管消融治疗等。 , cover=, journalId=null, articlesId=null, associationId=206, associationName=欧洲心律学会, associationIntro=欧洲心律学会（EHRAE,uropean Heart Rhythm Association)是欧洲心脏病学会的分支，致力于心律失常的预防与管理，以减少心律失常对患者的影响,减少心源性猝死。官方杂志《欧洲心律失常杂志》影响因子为1.839, copyright=0, guiderPublishedTime=Fri Mar 16 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年3月，欧洲心律学会(EHRA)发布了内分泌疾病患者的心律失常管理和设备治疗的意见书，内分泌疾病和各种类型型心律失常相关，包括房颤，室性心动过速，室颤以及心动过缓。本文主要内容包括特殊内分泌疾病心律失常的管理，内分泌疾病相关心律失常的预防以及卒中风险评估，内分泌疾病相关性心律失常的导管消融治疗等。</P> <P> </P>拓展指南：<strong>与<font color=red>心律失常</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=344f71c0015699ab" title="2018 EHRA/HRS/APHRS/LAHRS专家共识：心律失常和认知功能" target=_blank>2018 EHRA/HRS/APHRS/LAHRS专家共识：心律失常和认知功能</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2c8a51c001561ab6" title="2017 AHA/ACC/HRS室性心律失常处理与预防心脏猝死指南释要" target=_blank>2017 AHA/ACC/HRS室性心律失常处理与预防心脏猝死指南释要</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=570771c0015590ff" title="2018 EHRA/ESC共识：抗心律失常药物的临床用药及临床决策制定" target=_blank>2018 EHRA/ESC共识：抗心律失常药物的临床用药及临床决策制定</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2c5a71c001555576" title="中国儿童心律失常导管消融专家共识解读" target=_blank>中国儿童心律失常导管消融专家共识解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=85ae41c0015a55a1" title="中国儿童心律失常导管消融专家共识" target=_blank>中国儿童心律失常导管消融专家共识</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8" target=_blank>有关心律失常更多指南</a></ul>, tagList=[TagDto(tagId=10098, tagName=内分泌疾病), TagDto(tagId=318, tagName=心律失常)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5243, appHits=219, showAppHits=0, pcHits=3776, showPcHits=1618, likes=176, shares=4, comments=7, approvalStatus=1, publishedTime=Thu Mar 29 12:42:10 CST 2018, publishedTimeString=2018-03-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 29 12:42:10 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:38:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 EHRA意见书：内分泌疾病患者的心律失常管理和设备治疗)])
2018 EHRA意见书：内分泌疾病患者的心律失常管理和设备治疗
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=306922, encodeId=7bf93069227d, content=看不太懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2a2326445, createdName=吴匡靖, createdTime=Wed Apr 18 10:11:15 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303894, encodeId=1124303894aa, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Apr 08 12:20:29 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303880, encodeId=5d1d303880e7, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e71967716, createdName=易彭, createdTime=Sun Apr 08 11:26:46 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300987, encodeId=170f30098ea4, content=多谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/6f2d63c799d68129300901eb0e962dd4.jpg, createdBy=ddf12178538, createdName=小贝熊, createdTime=Fri Mar 30 00:32:57 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300879, encodeId=d2b63008e9c1, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Mar 29 15:18:48 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-04-18 吴匡靖

    看不太懂

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=306922, encodeId=7bf93069227d, content=看不太懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2a2326445, createdName=吴匡靖, createdTime=Wed Apr 18 10:11:15 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303894, encodeId=1124303894aa, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Apr 08 12:20:29 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303880, encodeId=5d1d303880e7, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e71967716, createdName=易彭, createdTime=Sun Apr 08 11:26:46 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300987, encodeId=170f30098ea4, content=多谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/6f2d63c799d68129300901eb0e962dd4.jpg, createdBy=ddf12178538, createdName=小贝熊, createdTime=Fri Mar 30 00:32:57 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300879, encodeId=d2b63008e9c1, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Mar 29 15:18:48 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-04-08 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=306922, encodeId=7bf93069227d, content=看不太懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2a2326445, createdName=吴匡靖, createdTime=Wed Apr 18 10:11:15 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303894, encodeId=1124303894aa, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Apr 08 12:20:29 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303880, encodeId=5d1d303880e7, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e71967716, createdName=易彭, createdTime=Sun Apr 08 11:26:46 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300987, encodeId=170f30098ea4, content=多谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/6f2d63c799d68129300901eb0e962dd4.jpg, createdBy=ddf12178538, createdName=小贝熊, createdTime=Fri Mar 30 00:32:57 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300879, encodeId=d2b63008e9c1, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Mar 29 15:18:48 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-04-08 易彭

    阅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=306922, encodeId=7bf93069227d, content=看不太懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2a2326445, createdName=吴匡靖, createdTime=Wed Apr 18 10:11:15 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303894, encodeId=1124303894aa, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Apr 08 12:20:29 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303880, encodeId=5d1d303880e7, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e71967716, createdName=易彭, createdTime=Sun Apr 08 11:26:46 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300987, encodeId=170f30098ea4, content=多谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/6f2d63c799d68129300901eb0e962dd4.jpg, createdBy=ddf12178538, createdName=小贝熊, createdTime=Fri Mar 30 00:32:57 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300879, encodeId=d2b63008e9c1, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Mar 29 15:18:48 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-03-30 小贝熊

    多谢分享.学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=306922, encodeId=7bf93069227d, content=看不太懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2a2326445, createdName=吴匡靖, createdTime=Wed Apr 18 10:11:15 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303894, encodeId=1124303894aa, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Apr 08 12:20:29 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303880, encodeId=5d1d303880e7, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e71967716, createdName=易彭, createdTime=Sun Apr 08 11:26:46 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300987, encodeId=170f30098ea4, content=多谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/6f2d63c799d68129300901eb0e962dd4.jpg, createdBy=ddf12178538, createdName=小贝熊, createdTime=Fri Mar 30 00:32:57 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300879, encodeId=d2b63008e9c1, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Mar 29 15:18:48 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-03-29 1ddf0692m34(暂无匿称)

    学习了.长知识

    0